These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17910907)

  • 1. Androgenic alopecia may have evolved to protect men from prostate cancer by increasing skin exposure to ultraviolet radiation.
    Kabai P
    Med Hypotheses; 2008; 70(5):1038-40. PubMed ID: 17910907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Might early baldness protect from prostate cancer by increasing skin exposure to ultraviolet radiation?
    Kabai P
    Cancer Epidemiol; 2010 Aug; 34(4):507. PubMed ID: 20451486
    [No Abstract]   [Full Text] [Related]  

  • 3. Baldness, benign prostate hyperplasia, prostate cancer and androgen levels.
    Faydaci G; Bilal E; Necmettin P; Fatih T; Asuman O; Uğur K
    Aging Male; 2008 Dec; 11(4):189-92. PubMed ID: 19172550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased risk of prostate cancer after skin cancer diagnosis: a protective role of ultraviolet radiation?
    de Vries E; Soerjomataram I; Houterman S; Louwman MW; Coebergh JW
    Am J Epidemiol; 2007 Apr; 165(8):966-72. PubMed ID: 17255116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased DHT levels in androgenic alopecia have been selected for to protect men from prostate cancer.
    Bhargava S
    Med Hypotheses; 2014 Apr; 82(4):428-32. PubMed ID: 24548754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UV radiation and cancer prevention: what is the evidence?
    Krause R; Matulla-Nolte B; Essers M; Brown A; Hopfenmüller W
    Anticancer Res; 2006; 26(4A):2723-7. PubMed ID: 16886683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broad-spectrum sunscreens provide better protection from solar ultraviolet-simulated radiation and natural sunlight-induced immunosuppression in human beings.
    Moyal DD; Fourtanier AM
    J Am Acad Dermatol; 2008 May; 58(5 Suppl 2):S149-54. PubMed ID: 18410801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen signaling and its interactions with other signaling pathways in prostate cancer.
    Kaarbø M; Klokk TI; Saatcioglu F
    Bioessays; 2007 Dec; 29(12):1227-38. PubMed ID: 18008377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5alpha-reductase inhibitors in benign prostatic hyperplasia and prostate cancer risk reduction.
    Rittmaster RS
    Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):389-402. PubMed ID: 18471794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.
    Yang Q; Titus MA; Fung KM; Lin HK
    J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between timing of exposure to ultraviolet radiation, T-stage and survival in prostate cancer.
    Rukin N; Blagojevic M; Luscombe CJ; Liu S; Saxby MF; Ramachandran S; Fryer AA; Jones PW; Strange RC
    Cancer Detect Prev; 2007; 31(6):443-9. PubMed ID: 18061372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgenic alopecia is not useful as an indicator of men at high risk of prostate cancer.
    Cremers RG; Aben KK; Vermeulen SH; den Heijer M; van Oort IM; Kiemeney LA
    Eur J Cancer; 2010 Dec; 46(18):3294-9. PubMed ID: 20561779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic damage by UVA radiation and pollutants.
    Burke KE; Wei H
    Toxicol Ind Health; 2009; 25(4-5):219-24. PubMed ID: 19651790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgenic alopecia: a counterproductive outcome of the anabolic effect of androgens.
    Soni VK
    Med Hypotheses; 2009 Sep; 73(3):420-6. PubMed ID: 19477078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways.
    Vis AN; Schröder FH
    BJU Int; 2009 Aug; 104(4):438-48. PubMed ID: 19558559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Male pattern baldness and the risk of prostate cancer.
    Yassa M; Saliou M; De Rycke Y; Hemery C; Henni M; Bachaud JM; Thiounn N; Cosset JM; Giraud P
    Ann Oncol; 2011 Aug; 22(8):1824-7. PubMed ID: 21324955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgens and prevention of prostate cancer.
    Sarvis JA; Thompson IM
    Curr Opin Endocrinol Diabetes Obes; 2008 Jun; 15(3):271-7. PubMed ID: 18438176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of phytoestrogens on prostate cancer and benign prostatic hyperplasia].
    Feng Y; Xia XY; Huang YF
    Zhonghua Nan Ke Xue; 2007 May; 13(5):457-61. PubMed ID: 17569267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclinical speckled perifollicular melanosis of the scalp.
    Petit L; Claudine ; Piérard-Franchimont ; Saint Léger D; Loussouarn G; Piérard GE
    Eur J Dermatol; 2002; 12(6):565-8. PubMed ID: 12459529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herbal/hormonal dietary supplement possibly associated with prostate cancer progression.
    Shariat SF; Lamb DJ; Iyengar RG; Roehrborn CG; Slawin KM
    Clin Cancer Res; 2008 Jan; 14(2):607-11. PubMed ID: 18223237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.